Found 4 matching trials
Expanded Access Program for Participants Who Completed Study 13-601 and Continue to Clinically Benefit From Cerdulatinib
N/AThis expanded access program will provide continued access to cerdulatinib ...
Status
No Longer Available
Location
Multiple Locations
Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
PHASE2This is a phase 2a, randomized, double-blind, vehicle-controlled study to a...
Location
Dermavant Investigational Site
CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)
PHASE2This is an open-label, multinational study of cerdulatinib in patients with...
Location
Multiple Locations
Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL
PHASE1This study will identify the highest dose, and assess the safety, of cerdul...
Location
Multiple Locations